Sst2 is a Key Outcome Biomarker in COVID-19: Insights from Discovery Randomized Trial
David M Smadja, Clément R Massonnaud,Aurélien Philippe,Mickael Rosa, Sophie Luneau,Antoine Rauch, Nathan Peiffer-Smadja,Amandine Gagneux-Brunon,Julien Poissy, Maxime Gruest,Alexandre Ung,Valérie Pourcher,François Raffi,Lionel Piroth,Kévin Bouiller, Hélène Esperou,Christelle Delmas,Drifa Belhadi,Alpha Diallo, Juliette Saillard,Aline Dechanet, Noémie Mercier,Axelle Dupont,François-Xavier Lescure,François Goehringer,Stéphane Jaureguiberry,François Danion, Violaine Tolsma,André Cabie, Johan Courjon, Sylvie Leroy,Joy Mootien,Bruno Mourvillier,Sébastien Gallien, Jean-Philippe Lanoix,Elisabeth Botelho-Nevers, Florent Wallet,Jean-Christophe Richard,Jean Reuter,Alexandre Gaymard, Richard Greil,Guillaume Martin-Blondel,Claire Andrejak,Yazdan Yazdanpanah,Charles Burdet,Jean-Luc Diehl,Maya Hites,Florence Ader,Sophie Susen,France Mentré,Annabelle Dupont, Discovery Study Group Scientific reports（2025）
Key words
SARS-CoV-2,COVID-19,Angiogenesis,Fibrosis,ST2
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper